Lim Seong Hai Capital Berhad (KLSE:LSH)
1.220
-0.030 (-2.40%)
At close: Nov 20, 2026
KLSE:LSH Revenue
Lim Seong Hai Capital Berhad had revenue of 112.73M MYR in the quarter ending June 30, 2026, a decrease of -7.51%. This brings the company's total for the last twelve months to 500.28M, up 22.15% year-over-year. In the fiscal year ending September 30, 2025, Lim Seong Hai Capital Berhad had annual revenue of 459.09M with 27.03% growth. That makes Lim Seong Hai Capital Berhad the 21,281st largest company in the world by revenue and 331st in Malaysia.
Revenue (ttm)
500.28M
Revenue Growth
+22.15%
P/S Ratio
2.04
Revenue / Employee
n/a
Employees
483
Market Cap
1.02B
Revenue by Segment
- Business of Construction 284.92M 40.6%
- Property Development 158.60M 22.6%
- Construction - Distribution And/Or Retail of Building Materials, Lighting Products and Related Mechanical and Electrical Products and Services 118.12M 16.9%
- Construction - Wholesale and Retail of Hardware and Tools, and Rental of Machinery 56.40M 8.0%
- Investment Holding 41.48M 5.9%
- Facilities Management 23.28M 3.3%
- Provision of Construction and Business Related Services & Solutions 18.19M 2.6%
Fiscal year ended Sep 30, 2025 See the full KLSE:LSH breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 459.09M | 97.68M | 27.03% |
| Sep 30, 2024 | 361.41M | 3.65M | 1.02% |
| Sep 30, 2023 | 357.75M | 191.89M | 115.69% |
| Sep 30, 2022 | 165.87M | 98.45M | 146.03% |
| Sep 30, 2021 | 67.42M | 19.29M | 40.09% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Capital A Berhad | 2.61B |
| Padini Holdings Berhad | 1.88B |
| Malaysian Resources Corporation Berhad | 1.18B |
| Duopharma Biotech Berhad | 916.98M |
| Crescendo Corporation Berhad | 817.39M |
| JCY International Berhad | 589.17M |
| Master Tec Group Berhad | 556.02M |
| Infomina Berhad | 297.45M |